bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.07.14.549002

A Multimodal Vision Transformer for InterpretableFusion of Functional and Structural NeuroimagingData

Abstract

Deep learning models, despite their potential for increasing our understanding of intricate neuroimaging data, can be hampered by challenges related to interpretability. Multimodal neuroimaging appears to be a promising approach that allows us to extract supplementary information from various imaging modalities. Its noteworthy that functional brain changes are often more pronounced in schizophrenia, albeit potentially less reproducible, while structural MRI effects are more replicable but usually manifest smaller effects. Instead of conducting isolated analyses for each modality, the joint analysis of these data can bolster the effects and further refine our neurobiological understanding of schizophrenia. This paper introduces a novel deep learning model, the multimodal vision transformer (MultiViT), specifically engineered to enhance the accuracy of classifying schizophrenia by using structural MRI (sMRI) and functional MRI (fMRI) data independently and simultaneously leveraging the combined information from both modalities. This study uses functional network connectivity data derived from a fully automated independent component analysis method as the fMRI features and segmented gray matter volume (GMV) as the sMRI features. These offer sensitive, high-dimensional features for learning from structural and functional MRI data. The resulting MultiViT model is lightweight and robust, outperforming unimodal analyses. Our approach has been applied to data collected from control subjects and patients with schizophrenia, with the MultiViT model achieving an AUC of 0.833, which is significantly higher than the average 0.766 AUC for unimodal baselines and 0.78 AUC for multimodal baselines. Advanced algorithmic approaches for predicting and characterizing these disorders have consistently evolved, though subject and diagnostic heterogeneity pose significant challenges. Given that each modality provides only a partial representation of the brain, we can gather more comprehensive information by harnessing both modalities than by relying on either one independently. Furthermore, we conducted a saliency analysis to gain insights into the co-alterations in structural gray matter and functional network connectivity disrupted in schizophrenia. While its clear that the MultiViT model demonstrates differences compared to previous multimodal methods, the specifics of how it compares to methods such as MCCA and JICA are still under investigation, and more research is needed in this area. The findings underscore the potential of interpretable multimodal data fusion models like the MultiViT, highlighting their robustness and potential in the classification and understanding of schizophrenia.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bi, Y., Abrol, A., Fu, Z., Calhoun, V.. 2023-07-18. A Multimodal Vision Transformer for InterpretableFusion of Functional and Structural NeuroimagingData. https://doi.org/10.1101/2023.07.14.549002

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗